This trial looks at whether monitoring with MRI scans alone is as good as the combination of PCI with MRI scans for treating patients with small cell lung cancer.
1 Primary · 6 Secondary · Reporting Duration: Baseline to first neurocognitive failure CF or death due to any cause, assessed up to 12 months after randomization
Active Control
Experimental Treatment
668 Total Participants · 2 Treatment Groups
Primary Treatment: Magnetic Resonance Imaging · No Placebo Group · Phase 3
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Texas | 50.0% |
Louisiana | 50.0% |
65+ | 50.0% |
18 - 65 | 50.0% |
East Jefferson General Hospital | 50.0% |
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center | 50.0% |
Met criteria | 100.0% |